QHSLab, Inc.

Equities

USAQ

US90350R1077

Healthcare Facilities & Services

Market Closed - OTC Markets Other stock markets 07:29:22 13/06/2024 pm IST			5-day change	1st Jan Change
0.23 ^USD	+2.95%		+42.77%	+155.56%

13/05	QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
27/03	QHSLab, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022

May 17, 2022 at 01:47 am IST

QHSLab, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was USD 0.35533 million compared to USD 0.304336 million a year ago. Net loss was USD 0.190304 million compared to USD 0.086686 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago.

Latest news about QHSLab, Inc.

QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05	CI
QHSLab, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03	CI
QHSLab, Inc. Integrates Digital Medicine Assessments into Prominent Electronic Health Record Company	30/01	CI
Earnings Flash (USAQ) QHSLAB Reports Q3 Revenue $336,407	14/11	MT
QHSLab, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
QHSLab, Inc. Welcomes Six New Integrated Service Program Customer Accounts and Launches Enhanced Website for Improved Customer Engagement	25/23/25	CI
QHSLab, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/23/10	CI
QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	13/23/13	CI
QHSLab, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	30/23/30	CI
QHSLab, Inc. Auditor Raises 'Going Concern' Doubt	29/23/29	CI
QHSLab, Inc. Announces Representation Agreement with Healthcare Information Technology	16/23/16	CI
QHSLab, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
QHSLab, Inc. Meets the Demand for Updated Mental Health Screening Recommendations from the U.S. Preventive Services Task Force	01/22/01	CI
Qhslab, Inc. Launches A “Long Covid” Digital Health Tool for Primary Care Physicians	20/22/20	CI
QHSLab, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
QHSLab, Inc. announced that it has received $0.4 million in funding from Mercer Street Capital Partners, LLC	26/22/26	CI
QHSLab, Inc. announced that it expects to receive $0.4 million in funding from Mercer Street Capital Partners, LLC	21/22/21	CI
QHSLab, Inc. Announces New Strategic Alliance with Medical License Factory, LLC for Its AllergiEnd Products and Services	24/22/24	CI
QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	17/22/17	CI
USA Equities Corp. has Changed its Name to QHSLab, Inc	19/22/19	CI
USA Equities Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	01/22/01	CI
USA Equities Corp. Auditor Raises 'Going Concern' Doubt	01/22/01	CI
USA Equities Corp. has Changed its Name to QHSLab, Inc	18/22/18	CI
USA Equities Corp. Introduces AllergiQT?? Quick Test, Further Expanding Market Presence	29/21/29	CI
USA Equities Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	16/21/16	CI

Chart QHSLab, Inc.

Duration

Period

More charts

Company Profile

QHSLab, Inc. is a medical device technology and software-as-a-service (SaaS) company. The Company focuses on enabling primary care physicians (PCPs) to increase their revenues by providing them with tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures. The products that the Company provides its physician clients enables them to diagnose and treat patients with chronic diseases The Company is engaged in providing PCPs with the software, training and devices necessary that allow them to treat their patients using value-based healthcare, informatics and algorithmic personalized medicine. Its digital healthcare, clinical decision support and point of care solutions also support non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and are reimbursable to medical practice.

Sector

Healthcare Facilities & Services

Calendar

12/11/2024 - Q3 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
QHSLAB, INC.	+155.56%	23.5L
HCA HEALTHCARE, INC.	+25.94%	8.93TCr
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+3.24%	2.69TCr
FRESENIUS SE & CO. KGAA	+5.59%	1.81TCr
LABCORP HOLDINGS INC.	-13.56%	1.66TCr
QUEST DIAGNOSTICS INCORPORATED	+0.47%	1.54TCr
NATERA, INC.	+76.87%	1.36TCr
TENET HEALTHCARE CORPORATION	+84.57%	1.36TCr
FRESENIUS MEDICAL CARE AG	+1.77%	1.22TCr
PURE HEALTH HOLDING	-24.74%	1.27TCr

Other Healthcare Facilities & Services

QHSLab, Inc.

Equities

USAQ

US90350R1077

Healthcare Facilities & Services

QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022

Latest news about QHSLab, Inc.

Chart QHSLab, Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Other Healthcare Facilities & Services